In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. Pharmacopeia Ramps Up Drug Quality, Safety Cooperation Across Asia With Four New Agreements With China, ASEAN States

This article was originally published in PharmAsia News

Executive Summary

BEIJING - In moves that could ultimately help elevate safety and quality standards for drugs produced across Asia, including those exported to North America, the United States Pharmacopeial Convention has signed a series of agreements with China and the Association of Southeast Asian Nations on closer scientific exchanges and joint testing of pharmaceuticals

You may also be interested in...



USP Looks To Maximize Opportunity As China Builds Drug Standards

A relationship initiated in the wake of a fatal heparin scandal between USP and the China Pharmacopeia Commission is going strong, presenting opportunities for companies like Sanofi and China’s Tasly as the Middle Kingdom gets set to expand drug standards.

USP Looks To Maximize Opportunity As China Builds Drug Standards

A relationship initiated in the wake of a fatal heparin scandal between USP and the China Pharmacopeia Commission is going strong, presenting opportunities for companies like Sanofi and China’s Tasly as the Middle Kingdom gets set to expand drug standards.

After Signing Pact With Chinese Regulators, U.S. Pharmacopeia Seeks To Develop New Tests To Help Prevent Deadly Episodes of Adulteration

BEIJING - After signing an agreement on cooperation with China's Center for Disease Control and Prevention in the wake of a series of contaminated drug and food scandals, leaders of the U.S. Pharmacopeial Convention are working to develop new tests that could be used to safeguard the global supply chain

Related Content

UsernamePublicRestriction

Register

SC072029

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel